Forte Biosciences (FBRX) Notes Payables (2016 - 2020)
Historic Notes Payables for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to $5.0 million.
- Forte Biosciences' Notes Payables rose 12599.82% to $5.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.0 million, marking a year-over-year increase of 12599.82%. This contributed to the annual value of $4.7 million for FY2019, which is N/A changed from last year.
- As of Q1 2020, Forte Biosciences' Notes Payables stood at $5.0 million, which was up 12599.82% from $4.7 million recorded in Q4 2019.
- Over the past 5 years, Forte Biosciences' Notes Payables peaked at $27.8 million during Q3 2019, and registered a low of $2.2 million during Q1 2019.
- Moreover, its 5-year median value for Notes Payables was $7.2 million (2016), whereas its average is $7.9 million.
- As far as peak fluctuations go, Forte Biosciences' Notes Payables tumbled by 6938.89% in 2019, and later skyrocketed by 12599.82% in 2020.
- Forte Biosciences' Notes Payables (Quarter) stood at $7.2 million in 2016, then changed by 0.0% to $7.2 million in 2017, then changed by 0.0% to $7.2 million in 2018, then tumbled by 34.11% to $4.7 million in 2019, then grew by 5.0% to $5.0 million in 2020.
- Its last three reported values are $5.0 million in Q1 2020, $4.7 million for Q4 2019, and $27.8 million during Q3 2019.